Stanford | GenomeWeb

Stanford

Stanford researchers develop a low-cost centrifuge inspired by a whirligig toy.

For New Skin

Technology Review writes that gene therapy might be able to help people with epidermolysis bullosa.

The team identified gene expression patterns that can determine how severe a patient's systemic sclerosis is and if treatment has been effective. 

The organizations in the consortium will identify, characterize, and catalog human biological molecules affected by physical activity in volunteer biosamples.

DNAnexus customers now have a choice of two cloud platforms and ancillary tools and the company has access to a wider pool of potential users.

The new assays — one targeting 17 genes and one targeting 77 genes — are based on the CAPP-Seq technology developed by Stanford University

Sickle Change

Stanford researchers use CRISPR to edit sickle cell mutations, possibly laying the groundwork for a clinical trial, Reuters reports.

Roche has licensed and plans to commercialize the circulating tumor DNA technology, which the Stanford researchers dubbed CAPP-seq.

The technologies will be added to ClearLight's portfolio for the three-dimensional interrogation and imaging of tissue samples.

The public-private consortium, led by the National Institute of Standards and Technology, recently released four new reference materials.

Pages

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.